We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research

News   Apr 16, 2012

 
ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research
 
 
 

RELATED ARTICLES

$3M Grant to Advance Drugs for ALS, Alzheimer's & Parkinson's

News

A new four-year, $3 million grant will enable Scripps Research scientists to advance compounds that may protect neurons in diseases caused by toxic protein accumulation, including Parkinson’s, ALS, Alzheimer’s and Creutzfeldt-Jakob disease.

READ MORE

A Way to Enhance Adsorption of Chemotherapy Drugs

News

A new study demonstrates adsorption of chemotherapy drugs onto active carbon delivery capsule can be enhanced with aluminium atom inclusions.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE